MF
GRNAW

Magnetar Financial’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Magnetar Financial’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-321,573
Closed -$386K – 1584
2021
Q4 		$386K Hold
321,573
– – ﹤0.01% 1018
2021
Q3 		$325K Buy
+321,573
New +$337K ﹤0.01% 993

Other funds holding GRNAW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

Magnetar Financial's GRNAW Position: Q1 2022 in Review

Magnetar Financial sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q1 2022, closing a stake of 321,573 shares — an estimated $386K sold.

Magnetar Financial first reported a position in GRNAW in Q3 2021 and held it in 2 quarters. The position peaked at $386K in Q4 2021. 27 funds tracked by Wall St. Rank hold GRNAW as of Q1 2022.

  • Magnetar Financial reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q1 2022 after selling out during the quarter.
  • Magnetar Financial sold 321,573 GreenLight Biosciences Holdings, PBC Warrant shares in Q1 2022, an estimated $386K.
  • Magnetar Financial first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q3 2021 and held it in 2 quarters.
  • Magnetar Financial's GreenLight Biosciences Holdings, PBC Warrant position peaked at $386K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q1 2022.

Based on Magnetar Financial's 13F filing for Q1 2022, filed 16 May 2022.